Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion

BACKGROUND: Two treatments, ranibizumab and dexamethasone implant, for visual impairment due to macular oedema (ME) secondary to retinal vein occlusion (RVO) have recently been studied in clinical trials. There have been no head to head comparisons of the two treatments, and improvement measured as...

Descripción completa

Detalles Bibliográficos
Autores principales: Thom, Howard HZ, Capkun, Gorana, Nixon, Richard M, Ferreira, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289570/
https://www.ncbi.nlm.nih.gov/pubmed/25533265
http://dx.doi.org/10.1186/1471-2288-14-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289570/
https://www.ncbi.nlm.nih.gov/pubmed/25533265
http://dx.doi.org/10.1186/1471-2288-14-140

Ejemplares similares